Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics
Abstract The development of cancer vaccines is based on the premise that tumor cells are potentially targetable by host immunity through the effective presentation of tumor‐associated antigens to reactive T‐cell populations. Vaccine efficacy may be limited by the functional properties of effector ce...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2021-06-01
|
| Col·lecció: | ImmunoMedicine |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/imed.1021 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|